 |
|
|
|
 |
|
|
| Article 1 to 10 out of 18 concerning MedMira Inc.
|
-
US Patent for Rapid Test Method and Technology Platform Awarded to MedMira
(07/18/2008)
MedMira Inc. announced that it received a Notice of Allowance from the United States Patent and Trademark Office for its rapid flow-through test (RFT) methodology, the technology platform its rapid tests are built on.This patent protects the core ...
-
MedMira Continues Momentum in Eastern Europe Expanding Distribution Network to Include Moldova and Ukraine
(04/29/2008)
Regional Distributor Enters New Markets with MiraCare and Multiplo Tests
MedMira Inc. announced that it continues to build sales momentum, expand into new sales territories, and extend its product reach in Eastern Europe. Building on an initial distribution channel in Romania MedMira is expanding its footprint in the ...
-
MedMira Files Patent Application for Next Generation Rapid Test
(03/19/2008)
MedMira Inc. announced that it has filed a patent application with the United States Patent Office for its new rapid test platform. MedMira's research & development team has been working on a next generation, rapid test based on the company's ...
-
MedMira Appoints New Executive for Global Business Development
(01/07/2008)
MedMira Inc. announced the appointment of Richard "Dick" Van Maanen to the position of Vice President of Global Business Development for the Company. Mr. Van Maanen is a 25-year veteran of the in vitro diagnostics industry, and has held sales, ...
-
MedMira Wins Government Tender in Russia
(12/10/2007)
MedMira Inc. announced that it has won an official government tender in the Republic of Tatarsan with its Multiplo(TM) Rapid HBV/HIV/HCV Antibody Test (Multiplo HBV/HIV/HCV). This success is the first in the Company's drive to penetrate the ...
-
MedMira's HIV Test Approved Under USAID Initiative
(11/20/2007)
Allows for International Purchase as Part of US Presidential Plan for AIDS Relief
MedMira Inc. announced that its Reveal G3 Rapid HIV-1 Antibody Test ("Reveal G3") has been approved for purchase by the U.S. Agency for International Development ("USAID"), resulting in the placement of Reveal G3 on USAID's rapid HIV test ...
-
MedMira CEO Hermes Chan Named Top Bioscience Innovator of 2007 by The Economist
(10/23/2007)
MedMira Inc. announced that company President and CEO, Hermes Chan was named the Top Bioscience Innovator of 2007 at The Economist's Sixth Annual Innovation Awards Ceremony and Summit last night in London, England. This prestigious international ...
-
MedMira's Biosensor Division to Receive $3 million from ACOA's Atlantic Innovation Fund
(01/19/2007)
Investment in Maple Biosciences Shall Support Development of Revolutionary Diagnostics
MedMira Inc. will receive up to $3 million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund. This financial contribution shall enable MedMira's biosensor division, Maple Biosciences, to undertake a $5.4 ...
-
MedMira Signs Italian Distributor for Rapid HIV Test
(11/27/2006)
MedMira Inc. announced that it has signed an exclusive distribution agreement with Italian distributor Voden Medical Instruments spa (Voden). Voden will distribute MedMira's MiraCare(TM) Rapid HIV Antibody Test (MiraCare HIV) to point-of-care and ...
-
MedMira's Biosensor Division to Collaborate with National Research Council on Breast Cancer Research
(11/17/2006)
MedMira Inc. announced that it has entered into a collaborative agreement with the National Research Council of Canada (NRC), through its biosensor division, Maple BioSciences. The agreement will allow NRC to work with Maple BioSciences on the ...
Additional information
MedMira Inc.
Halifax, NS, Canada
Company
|
|
|
|
|
|
Top
